Results 21 to 30 of about 446,414 (163)
Сибирский онкологический журнал, 2022 Gastric cancer (gc) is one of the most common cancers worldwide. The majority of newly diagnosed gastric cancer cases present with distant metastases. Peritoneal carcinomatosis (pc) is the most unfavorable type of progression of primary gc, which occurs ...
V. A. Markovich +10 more
doaj +1 more source
Pleura and Peritoneum, 2022 Peritoneal carcinomatosis is the most frequent site of metastases in patients with gastric cancer. Current standard treatment is palliative systemic chemotherapy with very poor prognosis.
Casella Francesco +10 more
doaj +1 more source
Initial Experience With Hyperthermic Intraperitoneal Chemotherapy [PDF]
Archives of Surgery, 2012 Until 2004, we treated peritoneal carcinomatosis with cytoreductive surgery accompanied by perioperative systemic chemotherapy. From October 2004, we decided to initiate a hyperthermic intraperitoneal chemotherapy (HIPEC) program for this condition.To determine the effect of HIPEC on postoperative outcomes at a single institution performing a high ...
Olivier, Turrini +6 more
openaire +2 more sources
Primary ovarian high-grade endometrial stromal sarcoma: a case report
Journal of Medical Case Reports, 2021 Background Primary ovarian high-grade endometrial stromal sarcoma is a very rare disease. Even though it has poor prognosis, the gold standard treatment has not been established owing to its rarity.
Ji Sun Lee +5 more
doaj +1 more source
World Journal of Surgical Oncology, 2020 Background Hepatopancreaticobiliary malignancies with peritoneal carcinomatosis exhibit poor survival with current therapies: hepatocellular carcinoma 11 months with sorafenib, and pancreaticobiliary 9–14 months with systemic chemotherapy.
Natasha Leigh +6 more
doaj +1 more source
Hyperthermic intraperitoneal chemotherapy (HIPEC) [PDF]
, 2013 Hemmer PHJ, Van Leeuwen BL. Hyperthermic intraperitoneal chemotherapy (HIPEC). Huisarts Wet 2013;56(1):36-9.Surgery forms the basis of cancer therapy, and surgical resection sometimes improves survival in metastatic disease. One such surgical approach is
Van Leeuwen, Barbara +2 more
core +1 more source
Technology in Cancer Research & Treatment, 2023 Despite extensive treatment with surgery and chemotherapy many patients with peritoneal metastases from colorectal cancer experience intraperitoneal disease relapse. The α-emitting 224 radium-labelled microparticle radionuclide therapeutic Radspherin® is
Ebbe Billmann Thorgersen MD, PhD +6 more
doaj +1 more source
Role of hyperthermic intraperitoneal chemotherapy in ovarian cancer [PDF]
Chinese Clinical Oncology, 2020 Epithelial ovarian cancer (EOC), has the highest worldwide mortality of all gynecological tumors, in 75% of cases is diagnosed in advanced stages. Despite of treatments with maximal cytoreductive surgery (CRS) and platinum-based chemotherapy (CT), approximately 70% of patients with advancedstage disease relapse within 18 months, given this high number ...
Juan Manuel, Medina-Castro +1 more
openaire +2 more sources
Pleura and Peritoneum, 2022 Two surgical techniques used for peritoneal metastasis involve a risk of exposure to antineoplastic drugs (ADs): hyperthermic intraperitoneal chemotherapy (HIPEC) and pressurized intraperitoneal aerosol chemotherapy (PIPAC).
Benoist Hubert +8 more
doaj +1 more source
Case Reports in Oncology, 2016 Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy has emerged as an aggressive treatment option with intent to either cure or extend disease-free survival of selected patients with peritoneal carcinomatosis.
Luiza Damian Ribeiro Barbosa +2 more
doaj +1 more source